DOI: 10.1073/pnas.2624362123 ISSN: 0027-8424
New molecular and historical evidence on ancient Egyptian embalming
Tim Berger, Amira Naimi, Kornelia Hardes, Claudia Sachße, Ricarda Gericke, Michael Marner, Felix Mühlemeyer, Tanja Pommerening, Raphael Reher
Mumia vera aegyptiaca
was a mummy-derived medicinal substance widely used in medieval and early modern medicine, yet its material composition and biological activity remain poorly understood. Here, we integrate Egyptological and pharmaceutical-historical analysis of 41 textual sources with LC–MS/MS-based metabolomics, molecular networking, machine-learning-assisted annotation, and bioactivity testing to investigate ancient Egyptian embalming materials and historical
Mumia vera
samples. We analyzed 24 objects from university and pharmacy museum collections, including historical
Mumia vera
products, mummified body parts, embalming residues, bandages, and two mummified skulls. Comparative metabolomics revealed substantial heterogeneity among materials labeled as
Mumia vera
, but also recurrent molecular signatures consistent with aged conifer resins, including oxidized abietane-type diterpenoids. Several samples contained
Aloe
-associated metabolites, including aloeresin A/D- and aloin-related compounds. These data reveal
Aloe
-associated metabolites in ancient Egyptian embalming-related materials and support the presence of
Aloe
spp.-derived exudates in selected samples. The convergence of molecular and textual evidence further raises the possibility that a previously unresolved Egyptian term from the 2nd millennium BC may refer to
Aloe
sp. or an
Aloe
-derived product. Comparative metabolomics also linked an inconspicuous powder sample to a specific mummified head, although their curatorial association had not been securely documented. Finally, a historical
Mumia vera aegyptiaca
extract modestly protected MDCK cells from influenza virus-induced cytopathic effects, whereas the isolated major compound 7-oxodehydroabietic acid was inactive on its own. Together, these findings show how integrating textual scholarship, pharmaceutical history, and molecular analysis can refine the interpretation of ancient Egyptian embalming practices, museum objects, and historical medicines.